AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2017
Jul 13, 2017
35066_dirs_2017-07-13_9fe5c3e7-7583-4305-bdc2-99a66e311b98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2017-07-11
Reporting Person: Schinazi Raymond F (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-11 | Common Stock | M | 1706978 | $0.047 | Acquired | 277227831 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-11 | Stock Options (Right to Buy) | $0.047 | M | 1706978 | Disposed | 2018-01-02 | Common Stock (1706978) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9044717 | Indirect |
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15